These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6414537)

  • 1. [Molecular structure and immunochemical properties of highly purified hemagglutinin from Clostridium botulinum type A].
    Ivanova LG; Blagoveshchenskiĭ VA; Vinogradova ID; Kolesnikova VA; Ugriumova GA
    Biokhimiia; 1983 Sep; 48(9):1548-54. PubMed ID: 6414537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of neurotoxin and hemagglutinin from Clostridium botulinum A and characterization of its neurotoxin].
    Vinogradova ID; Uvarova RN; Ivanov KK; Kazdobina IS; Bulatova TI
    Biokhimiia; 1983 May; 48(5):788-96. PubMed ID: 6409167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological properties of Hn-33 purified from type A Clostridium botulinum.
    Sharma SK; Singh BR
    J Nat Toxins; 2000 Nov; 9(4):357-62. PubMed ID: 11126514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hemagglutinin of Clostridium botulinum. Extraction, chemical characteristics and serologic specificity].
    Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):14-8. PubMed ID: 47673
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative immunochemical study of the hemagglutinins of Cl. botulinum A and B].
    Ivanova LG; Kliucheva VV; Blagoveshchenskiĭ VA; Lebedenko GI; Saprykina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):48-53. PubMed ID: 404806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on hemagglutinins (lectins) from plasma of murrel fish, family Channidae.
    Manihar SR; Varma KL; Das HR
    Indian J Biochem Biophys; 1990 Dec; 27(6):464-70. PubMed ID: 2129347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of hemagglutinin from Beauveria bassiana.
    Peczyńska-Czoch W; Zal T; Czerwiński M; Szulc M
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):319-24. PubMed ID: 1340189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis.
    Sharma SK; Singh BR
    J Nat Toxins; 1998 Oct; 7(3):239-53. PubMed ID: 9783262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of hemagglutinin of Clostridium botulinum type C strain Stockholm.
    Suzuki N; Syuto B; Kubo S
    Jpn J Vet Res; 1986 Oct; 34(3-4):269-78. PubMed ID: 3546890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Lotus tetragonolobus fucolectin components for differences in hemagglutinating and macrophage activating activities.
    Leu RW; Herriott MJ; Worley DS
    Immunobiology; 1985 Apr; 169(3):250-62. PubMed ID: 3997198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
    Zhou Y; Foss S; Lindo P; Sarkar H; Singh BR
    FEBS J; 2005 Jun; 272(11):2717-26. PubMed ID: 15943806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation of the theta-hemolysin of Cl. perfringens].
    Dolgikh MS; Blagoveshchenskiĭ VA; Sergeeva TI; Novoselova GN
    Vopr Med Khim; 1981; 27(1):129-32. PubMed ID: 6258318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and characterization of the polypeptide fragments obtained by limited proteolysis of botulinic toxin type A].
    Shibaeva IV; Kolesnikova VA; Kazdobina IS; Ivanov KK
    Biokhimiia; 1980 Sep; 45(9):1589-96. PubMed ID: 6788094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
    Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
    Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.